<DOC>
	<DOCNO>NCT01266434</DOCNO>
	<brief_summary>To test whether simvastatin additional anti-inflammatory effect p38 MAPK , signal molecule inflammation inhale steroid-treated asthmatic .</brief_summary>
	<brief_title>The Additive Anti-inflammatory Effect Simvastatin Combination With Inhaled Corticosteroids p38 MAPK Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>mildtomoderate persistent asthmatic FEV1 = OR &gt; 50 % predict Previous history renal disease serum creatinine 2 mg/dl . Previous history liver disease . Pregnancy lactation . Are already receive know allergic statin develop myositis . Have asthma exacerbation require treatment oral corticosteroid 3 month prior commencement study entry . Being treat immunosuppressive agent . Unwilling cooperate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>moderate persistent asthma</keyword>
	<keyword>Inhaled corticosteroid</keyword>
</DOC>